AI MARKET SCANNING

Lexicon Pharmaceuticals Inc

📅 Next Catalyst: Nov 05, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -2.67%
MAX GAP RECORD -20.00%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $LXRX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN)
-20.00%
May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN)
+3.12%
Mar 05, 2026 Earnings Release 2026-03-05 (BEFORE OPEN)
-5.52%
Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN)
+1.45%
Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN)
+6.67%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
-7.94%
Mar 06, 2025 Earnings Release 2025-03-06 (AFTER CLOSE)
+5.41%

VOLATILITY & GAP BIAS

AVG GAP MOVE 6.5%
Bullish Gaps (6)
Bearish Gaps (7)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $LXRX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗